• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢吡肟在体内释放出的N-甲基吡咯烷的N-氧化反应。

N-oxidation of N-methylpyrrolidine released in vivo from cefepime.

作者信息

Forgue S T, Kari P, Barbhaiya R

机构信息

Metabolism and Pharmacokinetics Department, Bristol-Myers Company, Syracuse, NY 13221-4755.

出版信息

Drug Metab Dispos. 1987 Nov-Dec;15(6):808-15.

PMID:2893706
Abstract

Cefepime (BMY-28142), 7-[alpha-(2-aminothiazol-4-yl)-alpha-(Z)-methoximin oacetamido] -3-[(1-methyl-1-pyrrolidino)-methyl]-3-cephem-4-carboxylate is a potent cephalosporin that is unique in having a quaternized N-methylpyrrolidino side chain. Degradation of the beta-lactam ring can result in release of N-methylpyrrolidine (NMP), an alicyclic tertiary amine. After iv bolus administration of [methyl-14C]NMP, most radioactivity in the urine of rats and a dog was present as a polar, nonextractable metabolite, which was isolated and identified as NMP N-oxide. A minor urinary metabolite was not identified. The NMP concentration in plasma declined in a rapid monoexponential manner, and there was a concomitant increase in the N-oxide concentration. After iv administration of cefepime, which was labeled with 14C in the methyl group of the NMP side chain, 86% of the radiolabel recovered in the urine was attributable to intact antibiotic. The balance was principally present as the N-oxide. Oxidation of NMP to the N-oxide by rat and human liver microsomes was demonstrable in vitro. These results indicate that intravenously administered NMP or NMP arising from the degradation of cefepime in vivo is subject to rapid metabolic clearance.

摘要

头孢吡肟(BMY - 28142),7 - [α - (2 - 氨基噻唑 - 4 - 基) - α - (Z) - 甲氧基亚氨基乙酰氨基] - 3 - [(1 - 甲基 - 1 - 吡咯烷基) - 甲基] - 3 - 头孢烯 - 4 - 羧酸是一种强效头孢菌素,其独特之处在于具有季铵化的N - 甲基吡咯烷基侧链。β - 内酰胺环的降解可导致N - 甲基吡咯烷(NMP)释放,N - 甲基吡咯烷是一种脂环族叔胺。静脉推注[甲基 - 14C]NMP后,大鼠和狗尿液中的大部分放射性以极性、不可萃取的代谢物形式存在,该代谢物被分离并鉴定为NMP N - 氧化物。一种次要的尿液代谢物未被鉴定。血浆中NMP浓度以快速单指数方式下降,同时N - 氧化物浓度增加。静脉注射在NMP侧链甲基上标记有14C的头孢吡肟后,尿液中回收的放射性标记物的86%归因于完整的抗生素。其余部分主要以N - 氧化物形式存在。在体外可证明大鼠和人肝微粒体将NMP氧化为N - 氧化物。这些结果表明,静脉注射的NMP或体内头孢吡肟降解产生的NMP会迅速被代谢清除。

相似文献

1
N-oxidation of N-methylpyrrolidine released in vivo from cefepime.头孢吡肟在体内释放出的N-甲基吡咯烷的N-氧化反应。
Drug Metab Dispos. 1987 Nov-Dec;15(6):808-15.
2
Disposition of the cephalosporin cefepime in normal and renally impaired subjects.头孢吡肟在正常受试者和肾功能受损受试者中的处置情况。
Drug Metab Dispos. 1991 Jan-Feb;19(1):68-73.
3
Metabolism and pharmacokinetics of a novel Src kinase inhibitor TG100435 ([7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine) and its active N-oxide metabolite TG100855 ([7-(2,6-dichloro-phenyl)-5-methylbenzo[1,2,4]triazin-3-yl]-{4-[2-(1-oxy-pyrrolidin-1-yl)-ethoxy]-phenyl}-amine).新型Src激酶抑制剂TG100435([7-(2,6-二氯苯基)-5-甲基苯并[1,2,4]三嗪-3-基]-[4-(2-吡咯烷-1-基乙氧基)-苯基]-胺)及其活性N-氧化物代谢物TG100855([7-(2,6-二氯苯基)-5-甲基苯并[1,2,4]三嗪-3-基]-{4-[2-(1-氧代-吡咯烷-1-基)乙氧基]-苯基}-胺)的代谢与药代动力学
Drug Metab Dispos. 2007 Jun;35(6):929-36. doi: 10.1124/dmd.106.014290. Epub 2007 Mar 19.
4
In vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation.ABT-418在黑猩猩(Pan troglodytes)体内的体外肝脏代谢。一种独特的微粒体含黄素单加氧酶依赖性立体选择性N'-氧化模式。
Drug Metab Dispos. 1995 Oct;23(10):1143-52.
5
Disposition and metabolism of 3-(3-chlorophenoxy)-N-methylpyrrolidine [14C]-carboxamide in the rat, dog, and man.3-(3-氯苯氧基)-N-甲基吡咯烷[14C] -羧酰胺在大鼠、狗和人体内的处置与代谢。
Drug Metab Dispos. 1976 Jul-Aug;4(4):379-86.
6
The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.胆碱能通道激活剂ABT - 418在大鼠、犬、食蟹猴和人类体内的体外肝脏代谢情况。
Drug Metab Dispos. 1994 Sep-Oct;22(5):788-98.
7
Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.III类抗心律失常药物MK-499在大鼠和犬体内的代谢。
Drug Metab Dispos. 1998 May;26(5):388-95.
8
Embryotoxic potential of N-methyl-pyrrolidone (NMP) and three of its metabolites using the rat whole embryo culture system.使用大鼠全胚胎培养系统研究N-甲基吡咯烷酮(NMP)及其三种代谢物的胚胎毒性潜力。
Toxicol Appl Pharmacol. 2009 Jun 1;237(2):154-67. doi: 10.1016/j.taap.2009.02.024. Epub 2009 Mar 10.
9
Metabolism of bepridil in laboratory animals and humans.苄普地尔在实验动物和人类中的代谢。
Drug Metab Dispos. 1988 Jan-Feb;16(1):69-77.
10
Metabolism of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737): identification of an unusual N-acetylglucosamine conjugate in the cynomolgus monkey.5-异丙基-6-(5-甲基-1,3,4-恶二唑-2-基)-N-(2-甲基-1H-吡咯并[2,3-b]吡啶-5-基)吡咯并[2,1-f][1,2,4]三嗪-4-胺(BMS-645737)的代谢:食蟹猴中一种不寻常的N-乙酰葡糖胺缀合物的鉴定
Drug Metab Dispos. 2008 Dec;36(12):2475-83. doi: 10.1124/dmd.108.022624. Epub 2008 Sep 11.

引用本文的文献

1
Development and validation of a volumetric absorptive microsampling- liquid chromatography mass spectrometry method for the analysis of cefepime in human whole blood: Application to pediatric pharmacokinetic study.建立并验证了一种基于体积吸收式微采样-液相色谱-质谱联用法,用于人全血中头孢吡肟的分析:在儿科药代动力学研究中的应用。
J Pharm Biomed Anal. 2020 Feb 5;179:113002. doi: 10.1016/j.jpba.2019.113002. Epub 2019 Nov 20.
2
Metabolism, Excretion, and Pharmacokinetics of [ C]-Cefiderocol (S-649266), a Siderophore Cephalosporin, in Healthy Subjects Following Intravenous Administration.健康受试者静脉注射[C]-头孢地尔(S-649266),一种铁载体头孢菌素后的代谢、排泄和药代动力学。
J Clin Pharmacol. 2019 Jul;59(7):958-967. doi: 10.1002/jcph.1386. Epub 2019 Feb 7.
3
Prospective monitoring of cefepime in intensive care unit adult patients.重症监护病房成年患者头孢吡肟的前瞻性监测。
Crit Care. 2010;14(2):R51. doi: 10.1186/cc8941. Epub 2010 Apr 1.
4
Pitfalls in cefepime titration from human plasma: plasma- and temperature-related drug degradation in vitro.头孢吡肟在人血浆中滴定的陷阱:体外与血浆和温度相关的药物降解
Antimicrob Agents Chemother. 2002 Nov;46(11):3654-6. doi: 10.1128/AAC.46.11.3654-3656.2002.
5
Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).抗假单胞菌β-内酰胺类药物通过便携式弹性泵(用于囊性纤维化患者的家庭治疗)和电动注射器(重症监护病房)进行潜在给药的比较稳定性研究。
Antimicrob Agents Chemother. 2002 Aug;46(8):2327-32. doi: 10.1128/AAC.46.8.2327-2332.2002.
6
Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects.头孢吡肟在健康受试者单次及多次静脉给药后的药代动力学。
Antimicrob Agents Chemother. 1992 Mar;36(3):552-7. doi: 10.1128/AAC.36.3.552.
7
Pharmacokinetics of cefepime dihydrochloride arginine in subjects with renal impairment.盐酸头孢吡肟精氨酸在肾功能不全受试者中的药代动力学。
Antimicrob Agents Chemother. 1992 Dec;36(12):2676-80. doi: 10.1128/AAC.36.12.2676.